Antineoplastic effects of Magnoliae officinalis in tumours other than hepatomas
Author:
- 5 June 2009
- journal article
- Published by Wiley in Liver International
- Vol. 29 (6) , 951-952
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Signaling pathway for TNF-α-induced MMP-9 expression: Mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cellsInternational Immunopharmacology, 2008
- Antimicrobial and antioxidant activities of Cortex Magnoliae Officinalis and some other medicinal plants commonly used in South-East AsiaChinese Medicine, 2008
- Involvement of p38 mitogen‐activated protein kinase pathway in honokiol‐induced apoptosis in a human hepatoma cell line (hepG2)Liver International, 2008
- Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancerEuropean Journal of Pharmacology, 2008
- Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer modelBMC Cancer, 2008
- Honokiol, a Constituent of Oriental Medicinal Herb Magnolia officinalis, Inhibits Growth of PC-3 Xenografts In vivo in Association with Apoptosis InductionClinical Cancer Research, 2008
- Anti-inflammatory effect of honokiol is mediated by PI3K/Akt pathway suppressionActa Pharmacologica Sinica, 2008
- Magnolol and honokiol enhance HL-60 human leukemia cell differentiation induced by 1,25-dihydroxyvitamin D3 and retinoic acidThe International Journal of Biochemistry & Cell Biology, 2005